Abstract
(Anesth Analg. 2023;136:1122–1132) Cesarean delivery (CD) is a common major surgery but frequently recoveries are uncomplicated. However, in some cases high pain levels during recovery last longer than expected, leading to continued postpartum opioid use. This circumstance is rare, but serious in those who experience it. One common method to reduce opioid use in this population is the prescription of gabapentin, though questions have been raised about its effectiveness. This study was designed to assess the effectiveness of gabapentin in stopping opioid use, reducing pain, and aiding in functional recovery for women who have continued pain after CD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
